AstraZeneca was already aware of the power that NASCAR has to drive brand awareness and brand preference to a captive national audience. Their COPD and asthma maintenance treatment, SYMBICORT (budesonide – formoterol fumarate dihydrate) was being regularly seen during :30 commercials as part of NASCAR broadcasts. While they were putting their product in front of a captive audience, they were still missing a vital piece of a successful NASCAR program that could authenticate their brand and life-changing treatments to a fan base that could benefit from it.
That’s when AstraZeneca, a global leader in research and science, teamed up with Austin Dillon and the No. 3 team to continue to raise awareness for COPD and SYMBICORT (budesonide – formoterol fumarate dihydrate). As a compliment to their traditional media placement, their RCR team partnership not only put the SYMBICORT (budesonide – formoterol fumarate dihydrate) brand on-track, it also produced an excellent series of unique content that lent a face to the brand in Daytona 500 Champion Austin Dillon.
Below you will find the first installment of the content produced by AstraZeneca: